Alfuzosin: Difference between revisions
Jump to navigation
Jump to search
Pat Palmer (talk | contribs) m (Text replacement - "United States" to "United States of America") |
mNo edit summary |
||
| Line 19: | Line 19: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 11:01, 8 July 2024
In medicine, alfuzosin is a selective antagonist of alpha1-adrenergic receptors.
History
Uroxatral brand of alfuzosin was approved by the Food and Drug Administration in the United States of America with a New Drug Application (NDA) in 2003.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2009.[2]
External links
The most up-to-date information about Alfuzosin and other drugs can be found at the following sites.
- Alfuzosin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Alfuzosin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Alfuzosin - Detailed information from DrugBank.